HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ji-Cheng Lv Selected Research

Complement Factor H (Factor H)

1/2020Variation in complement factor H affects complement activation in immunoglobulin A vasculitis with nephritis.
1/2018Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.
1/2016Rare Variants in the Complement Factor H-Related Protein 5 Gene Contribute to Genetic Susceptibility to IgA Nephropathy.
5/2015Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ji-Cheng Lv Research Topics

Disease

26IGA Glomerulonephritis (IGA Nephropathy)
03/2022 - 12/2007
19Proteinuria
02/2022 - 12/2007
3Hypertension (High Blood Pressure)
01/2022 - 12/2007
3Fibrosis (Cirrhosis)
10/2021 - 01/2018
3Nephritis
01/2020 - 01/2010
3Chronic Kidney Failure (Chronic Renal Failure)
01/2019 - 10/2015
3Renal Glycosuria
01/2015 - 03/2011
2Nephrotic Syndrome (Syndrome, Nephrotic)
01/2022 - 01/2012
2Kidney Diseases (Kidney Disease)
01/2022 - 01/2020
2Atrophy
01/2021 - 01/2018
2Vasculitis (Vasculitides)
01/2020 - 06/2012
2Membranous Glomerulonephritis (Membranous Nephropathy)
05/2017 - 01/2012
2Genetic Predisposition to Disease (Genetic Predisposition)
01/2016 - 10/2007
2Pre-Eclampsia (Preeclampsia)
11/2015 - 01/2014
1Genetic Risk Score
01/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
12/2020
1Hematuria
01/2020
1Infections
01/2020
1IgA Vasculitis (Purpura, Schoenlein Henoch)
01/2020
1Sclerosis
11/2019
1Inflammation (Inflammations)
02/2018
1Renal Insufficiency (Renal Failure)
01/2018
1Hyperuricemia
01/2018
1Reinfection
11/2017
1Necrosis
10/2015
1Systemic Vasculitis
10/2015
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2014
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2012
1Chronic Renal Insufficiency
01/2012
1Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome)
01/2010
1Venous Thrombosis (Deep-Vein Thrombosis)
12/2009

Drug/Important Bio-Agent (IBA)

13Immunoglobulin A (IgA)IBA
01/2022 - 10/2007
8CreatinineIBA
01/2022 - 12/2007
8Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2012
6Hydroxychloroquine (Plaquenil)FDA LinkGeneric
03/2022 - 01/2018
4Complement Factor H (Factor H)IBA
01/2020 - 05/2015
3galactosyl-deficient IgA1IBA
01/2022 - 03/2016
3Complement System Proteins (Complement)IBA
10/2021 - 01/2016
3Antigen-Antibody Complex (Immune Complex)IBA
10/2021 - 09/2017
3Immunologic Factors (Immunomodulators)IBA
11/2020 - 01/2018
3Glucose (Dextrose)FDA LinkGeneric
01/2015 - 03/2011
2AlbuminsIBA
01/2022 - 01/2016
2SteroidsIBA
12/2020 - 01/2012
2Adrenal Cortex Hormones (Corticosteroids)IBA
11/2019 - 01/2019
2Interleukin-6 (Interleukin 6)IBA
02/2018 - 09/2017
2CytokinesIBA
02/2018 - 01/2018
2AntibodiesIBA
09/2017 - 12/2009
2AutoantibodiesIBA
05/2017 - 10/2015
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2015 - 06/2012
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2012 - 09/2011
1COVID-19 VaccinesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1LipidsIBA
01/2022
1LectinsIBA
10/2021
1CC ChemokinesIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Viral AntigensIBA
01/2020
1Growth Hormone (Somatotropin)IBA
11/2019
1Triggering Receptor Expressed on Myeloid Cells-1IBA
02/2018
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2018
1Uric Acid (Urate)IBA
01/2018
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
11/2017
1Polysaccharides (Glycans)IBA
09/2017
1Immunoglobulin G (IgG)IBA
09/2017
1EpitopesIBA
05/2017
1Amino AcidsFDA Link
05/2017
1AntigensIBA
05/2017
1Histocompatibility Antigens Class IIIBA
05/2017
1Phospholipase A2 ReceptorsIBA
05/2017
1SymportersIBA
11/2014
1SodiumIBA
11/2014
1Genetic Markers (Genetic Marker)IBA
05/2014
1von Willebrand FactorIBA
01/2014
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014
1Tyrosine (L-Tyrosine)FDA Link
01/2014
1Pharmaceutical PreparationsIBA
09/2013
1DefensinsIBA
06/2012
1Vitamin DFDA LinkGeneric
01/2012
1CalcineurinIBA
01/2012
1Calcitriol (Calcijex)FDA LinkGeneric
01/2012
1Tacrolimus (Prograf)FDA LinkGeneric
01/2012
1Puromycin AminonucleosideIBA
01/2012
1HLA-DRB1 Chains (HLA DRB1)IBA
01/2010
1NPHS2 proteinIBA
12/2009
1Heparin (Liquaemin)FDA LinkGeneric
12/2009
1Platelet Factor 4IBA
12/2009

Therapy/Procedure

8Therapeutics
03/2022 - 01/2012
2Renal Replacement Therapy (Therapies, Renal Replacement)
01/2019 - 01/2017
1Transplantation
01/2018
1Kidney Transplantation
01/2018
1Cesarean Section (Caesarean Section)
11/2015